's, RA Capital Management solidified its position in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN
) even more today. This time, Ra Capital reported acquiring 1,795,000 shares of the company, raising its position to a total of around 22.3 million shares. The price paid by the fund amounts to $2.48 per share.
How The Debt Ceiling Increase Helped The Majority of Hedge Funds
Will Hedge Funds Take Over Fannie Mae and Freddie Mac?
Hedge Fund News: Larry Robbins, Alan Howard & Ken Griffin’s Bold Statement